Abstract: Prodrug formulations of insulin and insulin analogs are provided wherein the insulin peptide has been modified by an amide bond linkage of a dipeptide prodrug element. The prodrugs disclosed herein have extended half-lives and are converted to the active form at physiological conditions through a non-enzymatic reaction driven by chemical instability.
Type:
Grant
Filed:
September 23, 2015
Date of Patent:
August 20, 2019
Assignee:
Indiana Univeresity Researc and Technology Corporation
Inventors:
Richard D. Dimarchi, Binbin Kou, Fa Zhang, John P. Mayer